A citation-based method for searching scientific literature

Hanneke Coumou, Guus A Westerhof, Selma B de Nijs, Aeilko H Zwinderman, Elisabeth H Bel. Eur Respir J 2018
Times Cited: 31







List of co-cited articles
185 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A 15-year follow-up study of ventilatory function in adults with asthma.
P Lange, J Parner, J Vestbo, P Schnohr, G Jensen. N Engl J Med 1998
774
35

Severe exacerbations predict excess lung function decline in asthma.
T R Bai, J M Vonk, D S Postma, H M Boezen. Eur Respir J 2007
205
29


An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications.
Raed A Dweik, Peter B Boggs, Serpil C Erzurum, Charles G Irvin, Margaret W Leigh, Jon O Lundberg, Anna-Carin Olin, Alan L Plummer, D Robin Taylor. Am J Respir Crit Care Med 2011
22

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.
Kian Fan Chung, Sally E Wenzel, Jan L Brozek, Andrew Bush, Mario Castro, Peter J Sterk, Ian M Adcock, Eric D Bateman, Elisabeth H Bel, Eugene R Bleecker,[...]. Eur Respir J 2014
22


Cluster analysis and clinical asthma phenotypes.
Pranab Haldar, Ian D Pavord, Dominic E Shaw, Michael A Berry, Michael Thomas, Christopher E Brightling, Andrew J Wardlaw, Ruth H Green. Am J Respir Crit Care Med 2008
19

Mepolizumab treatment in patients with severe eosinophilic asthma.
Hector G Ortega, Mark C Liu, Ian D Pavord, Guy G Brusselle, J Mark FitzGerald, Alfredo Chetta, Marc Humbert, Lynn E Katz, Oliver N Keene, Steven W Yancey,[...]. N Engl J Med 2014
973
19

After asthma: redefining airways diseases.
Ian D Pavord, Richard Beasley, Alvar Agusti, Gary P Anderson, Elisabeth Bel, Guy Brusselle, Paul Cullinan, Adnan Custovic, Francine M Ducharme, John V Fahy,[...]. Lancet 2018
362
19

Asthma.
Alberto Papi, Christopher Brightling, Søren E Pedersen, Helen K Reddel. Lancet 2018
342
19

Factors associated with persistent airflow limitation in severe asthma.
A ten Brinke, A H Zwinderman, P J Sterk, K F Rabe, E H Bel. Am J Respir Crit Care Med 2001
223
16

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.
Ian D Pavord, Stephanie Korn, Peter Howarth, Eugene R Bleecker, Roland Buhl, Oliver N Keene, Hector Ortega, Pascal Chanez. Lancet 2012
16


Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program.
Wendy C Moore, Deborah A Meyers, Sally E Wenzel, W Gerald Teague, Huashi Li, Xingnan Li, Ralph D'Agostino, Mario Castro, Douglas Curran-Everett, Anne M Fitzpatrick,[...]. Am J Respir Crit Care Med 2010
16

Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma.
M J McGeachie, K P Yates, X Zhou, F Guo, A L Sternberg, M L Van Natta, R A Wise, S J Szefler, S Sharma, A T Kho,[...]. N Engl J Med 2016
233
16

Rate of decline of lung function in subjects with asthma.
J K Peat, A J Woolcock, K Cullen. Eur J Respir Dis 1987
275
16

Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma.
Mario Castro, Jonathan Corren, Ian D Pavord, Jorge Maspero, Sally Wenzel, Klaus F Rabe, William W Busse, Linda Ford, Lawrence Sher, J Mark FitzGerald,[...]. N Engl J Med 2018
459
16

Severe exacerbations and decline in lung function in asthma.
Paul M O'Byrne, Søren Pedersen, Carl Johan Lamm, Wan C Tan, William W Busse. Am J Respir Crit Care Med 2009
220
16


Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations.
Philip H Quanjer, Sanja Stanojevic, Tim J Cole, Xaver Baur, Graham L Hall, Bruce H Culver, Paul L Enright, John L Hankinson, Mary S M Ip, Jinping Zheng,[...]. Eur Respir J 2012
16

Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort.
Dominick E Shaw, Ana R Sousa, Stephen J Fowler, Louise J Fleming, Graham Roberts, Julie Corfield, Ioannis Pandis, Aruna T Bansal, Elisabeth H Bel, Charles Auffray,[...]. Eur Respir J 2015
231
12

An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.
Helen K Reddel, D Robin Taylor, Eric D Bateman, Louis-Philippe Boulet, Homer A Boushey, William W Busse, Thomas B Casale, Pascal Chanez, Paul L Enright, Peter G Gibson,[...]. Am J Respir Crit Care Med 2009
12


Mepolizumab and exacerbations of refractory eosinophilic asthma.
Pranabashis Haldar, Christopher E Brightling, Beverley Hargadon, Sumit Gupta, William Monteiro, Ana Sousa, Richard P Marshall, Peter Bradding, Ruth H Green, Andrew J Wardlaw,[...]. N Engl J Med 2009
12

Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial.
J Mark FitzGerald, Eugene R Bleecker, Parameswaran Nair, Stephanie Korn, Ken Ohta, Marek Lommatzsch, Gary T Ferguson, William W Busse, Peter Barker, Stephanie Sproule,[...]. Lancet 2016
505
12

Decline of lung function in adults with bronchial asthma.
C S Ulrik, P Lange. Am J Respir Crit Care Med 1994
150
12

Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials.
Mario Castro, James Zangrilli, Michael E Wechsler, Eric D Bateman, Guy G Brusselle, Philip Bardin, Kevin Murphy, Jorge F Maspero, Christopher O'Brien, Stephanie Korn. Lancet Respir Med 2015
541
12

Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial.
Romain A Pauwels, Søren Pedersen, William W Busse, Wan C Tan, Yu-Zhi Chen, Stefan V Ohlsson, Anders Ullman, Carl Johan Lamm, Paul M O'Byrne. Lancet 2003
451
12

Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study.
Nicola A Hanania, Sally Wenzel, Karin Rosén, Hsin-Ju Hsieh, Sofia Mosesova, David F Choy, Preeti Lal, Joseph R Arron, Jeffrey M Harris, William Busse. Am J Respir Crit Care Med 2013
478
12

Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma.
I H van Veen, A Ten Brinke, P J Sterk, J K Sont, S A Gauw, K F Rabe, E H Bel. Eur Respir J 2008
80
12

"T2-high" in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin.
Stelios Pavlidis, Kentaro Takahashi, Francois Ng Kee Kwong, Jiaxing Xie, Uruj Hoda, Kai Sun, Vahid Elyasigomari, Paul Agapow, Matthew Loza, Fred Baribaud,[...]. Eur Respir J 2019
37
12

Heterogeneity of phenotypes in severe asthmatics. The Belgian Severe Asthma Registry (BSAR).
F Schleich, G Brusselle, R Louis, O Vandenplas, A Michils, C Pilette, R Peche, M Manise, G Joos. Respir Med 2014
117
12

Lung function decline and variable airway inflammatory pattern: longitudinal analysis of severe asthma.
Christopher Newby, Joshua Agbetile, Beverley Hargadon, Will Monteiro, Ruth Green, Ian Pavord, Christopher Brightling, Salman Siddiqui. J Allergy Clin Immunol 2014
41
12

Asthma Exacerbations Associated with Lung Function Decline in Patients with Severe Eosinophilic Asthma.
Hector Ortega, Steven W Yancey, Oliver N Keene, Necdet B Gunsoy, Frank C Albers, Peter H Howarth. J Allergy Clin Immunol Pract 2018
24
16


Type 2 Biomarkers and Prediction of Future Exacerbations and Lung Function Decline in Adult Asthma.
Ruth Semprini, Mathew Williams, Alex Semprini, Alice McDouall, James Fingleton, Cecile Holweg, Mark Weatherall, Richard Beasley, Irene Braithwaite. J Allergy Clin Immunol Pract 2018
16
25

Chronic airway obstruction in a population-based adult asthma cohort: Prevalence, incidence and prognostic factors.
Helena Backman, Sven-Arne Jansson, Caroline Stridsman, Hana Muellerova, Keele Wurst, Linnea Hedman, Anne Lindberg, Eva Rönmark. Respir Med 2018
7
57


Treatable traits: toward precision medicine of chronic airway diseases.
Alvar Agusti, Elisabeth Bel, Mike Thomas, Claus Vogelmeier, Guy Brusselle, Stephen Holgate, Marc Humbert, Paul Jones, Peter G Gibson, Jørgen Vestbo,[...]. Eur Respir J 2016
387
9

Current evidence and future research needs for FeNO measurement in respiratory diseases.
Leif Bjermer, Kjell Alving, Zuzana Diamant, Helgo Magnussen, Ian Pavord, Giorgio Piacentini, David Price, Nicolas Roche, Joaquin Sastre, Mike Thomas,[...]. Respir Med 2014
101
9

Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease.
Peter Lange, Bartolome Celli, Alvar Agustí, Gorm Boje Jensen, Miguel Divo, Rosa Faner, Stefano Guerra, Jacob Louis Marott, Fernando D Martinez, Pablo Martinez-Camblor,[...]. N Engl J Med 2015
480
9

Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma.
Klaus F Rabe, Parameswaran Nair, Guy Brusselle, Jorge F Maspero, Mario Castro, Lawrence Sher, Hongjie Zhu, Jennifer D Hamilton, Brian N Swanson, Asif Khan,[...]. N Engl J Med 2018
320
9

Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications.
D Robinson, M Humbert, R Buhl, A A Cruz, H Inoue, S Korom, N A Hanania, P Nair. Clin Exp Allergy 2017
124
9


Importance of concomitant local and systemic eosinophilia in uncontrolled asthma.
Florence Nicole Schleich, Anne Chevremont, Virginie Paulus, Monique Henket, Maité Manise, Laurence Seidel, Renaud Louis. Eur Respir J 2014
102
9

Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study.
David B Price, Anna Rigazio, Jonathan D Campbell, Eugene R Bleecker, Christopher J Corrigan, Mike Thomas, Sally E Wenzel, Andrew M Wilson, Mary Buatti Small, Gokul Gopalan,[...]. Lancet Respir Med 2015
227
9

Standardisation of spirometry.
M R Miller, J Hankinson, V Brusasco, F Burgos, R Casaburi, A Coates, R Crapo, P Enright, C P M van der Grinten, P Gustafsson,[...]. Eur Respir J 2005
9

Simultaneously increased fraction of exhaled nitric oxide levels and blood eosinophil counts relate to increased asthma morbidity.
Andrei Malinovschi, Christer Janson, Magnus Borres, Kjell Alving. J Allergy Clin Immunol 2016
51
9

Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial.
Peter G Gibson, Ian A Yang, John W Upham, Paul N Reynolds, Sandra Hodge, Alan L James, Christine Jenkins, Matthew J Peters, Guy B Marks, Melissa Baraket,[...]. Lancet 2017
237
9

Tezepelumab in Adults with Uncontrolled Asthma.
Jonathan Corren, Jane R Parnes, Liangwei Wang, May Mo, Stephanie L Roseti, Janet M Griffiths, René van der Merwe. N Engl J Med 2017
330
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.